Monday, March 14
View complete programs on the online schedule.
Jazz Pharmaceuticals: Excessive Daytime Sleepiness (EDS) in OSA – A Complex and Challenging Reality
12:30pm – 2:00pm | Room 11
Chair: Luigi Ferini-Strambi (Italy)
Sleep Number: Can the sleeping environment be optimized to improve sleep quality?
12:30pm – 2:00pm | Room 13
Chair: Eve Van Cauter (United States)
Philips: Management of sleep patients with cardiovascular disease
12:30pm – 2:00pm | Room 14
Chair: Winfried Randerath (Germany)
Takeda Pharmaceuticals: Navigating Narcolepsy: The Science of Orexin and Diagnostic Challenges
12:30pm – 2:00pm | Room 15
Chair: Giuseppe Plazzi (Italy)
ProSomnus Sleep Technologies: Personalized Care and Precision Medicine in Sleep Apnea: Emerging Technologies and Latest trends in Treating Sleep Apnea with Non-CPAP Therapies
12:30pm – 2:00pm | Room 21
Chair: Edward Sall (United States)
Neurim Pharmaceuticals: Advances in insomnia in ASD – from research to clinical practice
12:30pm – 2:00pm | Room 22
Chair: Oliviero Bruni (Italy)
ResMed: A new way to run clinical research in sleep medicine: Why does it matter?
12:30pm – 2:00pm | Room 23
Chairs: Christoph Schöbel (Germany); Kimberly Sterling (United States)
Tuesday, March 15
View complete programs on the online schedule.
Idorsia: Insomnia – a wake-up call
12:30pm – 2:00pm | Room 11
Chair: Charles Morin (Canada)
Avadel Pharmaceuticals: Addressing patient needs in the advancement of narcolepsy treatment
12:30pm – 2:00pm | Room 13
Chairs: Yves Dauvilliers (France); Michael Thorpy (United States)
Bioprojet: EDS management in OSA, the new approaches
12:30pm – 2:00pm | Room 15
Chair: Maria Rosaria Bonsignore (Italy)
Nox Medical: Beyond the AHI
12:30pm – 2:00pm | Room 22
Chair: Carolina Lombardi (Italy)
ResMed: How to improve sleep apnoea management using Patient-Reported Outcome Measurements
12:30pm – 2:00pm | Room 23
Chairs: Kimberly Sterling (United States); Anita Simonds (United Kingdom)
Activinsights: Beyond actigraphy: accelerometry and sleep biomarkers from wearables
1:00pm – 1:45pm | Room 32
Chair: Joss Langford (United Kingdom)
Wednesday, March 16
View complete program on the online schedule.
NLS Pharmaceutics: Quilience (Mazindol ER) a new approach for Type I & Type II narcolepsy: POLARIS clinical development program
12:30pm – 2:00pm | Room 22
Chair: Michael Thorpy (United States)